Difference between revisions of "Team:EPFL"

Line 1: Line 1:
−
<html lang="en">
+
{{EPFL/Head}}
 +
<html>
  
−
<head>
+
<body>
−
  <title>iGEM EPFL 2018</title>
+
−
  <meta charset="utf-8">
+
−
  <meta name="viewport" content="width=device-width, initial-scale=1">
+
−
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">
+
  
−
</head>
+
  <div class="container-fluid bg-1 text-center">
 +
    <h1>CAPOEIRA</h1>
 +
    <img src="https://static.igem.org/mediawiki/2018/3/3e/T--EPFL--encapsulin.jpg" class="img-circle" alt="encapsulin" width="150" height="150">
 +
    <h3>Cancer Personalized Encapsulin Immunotherapy and Relapse Assay</h3>
 +
  </div>
  
−
<style>
+
  <div class="container bg-2 text-center">
−
   /* DEFAULT WIKI SETTINGS */
+
    <br>
 +
    <a href="https://2018.igem.org/Team:EPFL/Description"><strong>What is CAPOEIRA ?</strong></a>
 +
    <hr>
 +
    <p style="font-size:20px;">While cancer is still the disease of the 21st century, new insights and approaches are changing the landscape of cancer therapy. Cancer immunotherapy is becoming a key technique for the successful fight against cancer. The goal of cancer immunotherapy
 +
      is to harness the immune system in the fight against cancer. The project that the EPFL 2018 iGEM team is presenting is focused on the development of a new therapeutic approach to target specific types of cancer using immunotherapy methods, with
 +
      a focus on vaccines. Furthermore, the project aims to integrate the personalized medicine approaches, by using patient-specific neoantigens to trigger the immune system and produce the response against cancer. The project is exhaustive and can be
 +
      divided into the following parts:</p>
 +
    <br>
 +
   </div>
  
−
  /**************************************************************************************************************************************************************************************************/
 
  
−
   #home_logo,
+
   <div class="container-fluid text-center">
−
  #sideMenu {
+
    <div class="col-sm-3">
−
     display: none;
+
      <a href="#">
−
   }
+
      <img src="https://static.igem.org/mediawiki/2018/b/b0/T--EPFL--Detection.png" class="img-circle project_part" alt="detection" width="255" height="255"> <br>
 +
    </a>
 +
      <p><strong>Detection of cancer patient specific tumor mutations and neoantigens</strong></p>
 +
    </div>
 +
    <div class="col-sm-3">
 +
      <a href="#">
 +
      <img src="https://static.igem.org/mediawiki/2018/9/93/T--EPFL--vaccine.png" class="img-circle project_part" alt="Vaccine" width="255" height="255"> <br>
 +
      </a>
 +
      <p><strong>Expression of the neoantigens and the adjuvant using encapsulin</strong></p>
 +
     </div>
 +
    <div class="col-sm-3">
 +
      <a href="#">
 +
      <img src="https://static.igem.org/mediawiki/2018/1/1f/T--EPFL--Dendritic.png" class="img-circle project_part" alt="Dendritic" width="255" height="255"> <br>
 +
      </a>
 +
      <p><strong>Maturation of dendritic cells and T-cells</strong></p>
 +
    </div>
 +
    <div class="col-sm-3">
 +
      <a href="#">
 +
      <img src="https://static.igem.org/mediawiki/2018/3/3c/T--EPFL--follow_up.png" class="img-circle project_part" alt="follow_up" width="255" height="255"> <br>
 +
      </a>
 +
      <p><strong>Detection of cancer relapse using liquid biopsies of ctDNA and cancer miRNA</strong></p>
 +
    </div>
 +
   </div>
  
−
  #sideMenu,
 
−
  #top_title,
 
−
  .patrollink {
 
−
    display: none;
 
−
  }
 
−
 
−
  #content {
 
−
    margin-left: 0px;
 
−
    margin-top: -7px;
 
−
    padding: 0px;
 
−
    width: 100%;
 
−
  }
 
−
 
−
  body {
 
−
    background-color: white;
 
−
    padding-top: +20px;
 
−
  }
 
−
 
−
  #bodyContent h1,
 
−
  #bodyContent h2,
 
−
  #bodyContent h3,
 
−
  #bodyContent h4,
 
−
  #bodyContent h5 {
 
−
    margin-bottom: 0px;
 
−
  }
 
−
 
−
  .judges-will-not-evaluate {
 
−
    border: 4px solid #e4dede;
 
−
    padding: 2% !important;
 
−
    width: 92%!important;
 
−
  }
 
−
 
−
 
−
  /**************************************************************************************************************************************************************************************************/
 
−
 
−
  p {
 
−
    font-size: 20px;
 
−
  }
 
−
 
−
  .navbar {
 
−
    margin-top: +10px;
 
−
    margin-bottom: 0;
 
−
    background-color: #2d2d30;
 
−
    border: 0;
 
−
    font-size: 11px !important;
 
−
    letter-spacing: 4px;
 
−
  }
 
−
 
−
  .navbar li a,
 
−
  .navbar .navbar-brand {
 
−
    color: #d5d5d5 !important;
 
−
  }
 
−
 
−
  .navbar-nav li a:hover {
 
−
    color: #fff !important;
 
−
  }
 
−
 
−
  .navbar-nav li.active a {
 
−
    color: #fff !important;
 
−
    background-color: #29292c !important;
 
−
  }
 
−
 
−
  .navbar-default .navbar-toggle {
 
−
    border-color: solid;
 
−
  }
 
−
 
−
  .bg-1 {
 
−
    background-color: #1abc9c;
 
−
    /*grey*/
 
−
    color: #ffffff;
 
−
    padding-top: 70px;
 
−
    padding-bottom: 70px;
 
−
  }
 
−
 
−
  .bg-2 {
 
−
    font-size: 30px;
 
−
  }
 
−
</style>
 
−
 
−
<body>
 
−
  <nav class="navbar navbar-default navbar-fixed-top">
 
−
    <div class="container-fluid">
 
−
      <div class="navbar-header">
 
−
        <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
 
−
        <span class="icon-bar"></span>
 
−
        <span class="icon-bar"></span>
 
−
        <span class="icon-bar"></span>
 
−
      </button>
 
−
        <a class="navbar-brand" href="https://2018.igem.org/Team:EPFL">iGEM EPFL 2018</a>
 
−
      </div>
 
−
      <div class="collapse navbar-collapse" id="myNavbar">
 
−
        <ul class="nav navbar-nav navbar-right">
 
−
          <li><a href="https://2018.igem.org/Team:EPFL">HOME</a></li>
 
−
          <li><a href="https://2018.igem.org/wiki/index.php?title=Team:EPFL/Description&action=submit">PROJECT</a></li>
 
−
          <li><a href="#parts">PARTS</a></li>
 
−
          <li><a href="#safety">SAFETY</a></li>
 
−
          <li><a href="#HumanPractices">HUMAN PRACTICES</a></li>
 
−
          <li><a href="#Team">TEAM</a></li>
 
−
        </ul>
 
−
      </div>
 
−
    </div>
 
−
  </nav>
 
  
 +
</body>
  
 
</html>
 
</html>

Revision as of 18:16, 1 August 2018

iGEM EPFL 2018

CAPOEIRA

encapsulin

Cancer Personalized Encapsulin Immunotherapy and Relapse Assay


What is CAPOEIRA ?

While cancer is still the disease of the 21st century, new insights and approaches are changing the landscape of cancer therapy. Cancer immunotherapy is becoming a key technique for the successful fight against cancer. The goal of cancer immunotherapy is to harness the immune system in the fight against cancer. The project that the EPFL 2018 iGEM team is presenting is focused on the development of a new therapeutic approach to target specific types of cancer using immunotherapy methods, with a focus on vaccines. Furthermore, the project aims to integrate the personalized medicine approaches, by using patient-specific neoantigens to trigger the immune system and produce the response against cancer. The project is exhaustive and can be divided into the following parts:


detection

Detection of cancer patient specific tumor mutations and neoantigens

Vaccine

Expression of the neoantigens and the adjuvant using encapsulin

Dendritic

Maturation of dendritic cells and T-cells

follow_up

Detection of cancer relapse using liquid biopsies of ctDNA and cancer miRNA